Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Porcine CD21 Monoclonal Antibody-[FITC]

Cat. No.VD7N344

Product TypeAnimal-targeted Antibodies

Size 0.5 mg

Product Overview

BioVenic mouse monoclonal antibody is specific for porcine CD21. It can be applied to FCM, IHC and IP assays of porcine CD21.

Specifications

Application FCM; IHC; IP
Clonality Monoclonal
Classification Primary Antibody
Clone L12N12
Host Mouse
Target Species Porcine
Species Reactivity Porcine
Specificity Porcine CD21
Isotype IgG1
Purity > 90%
Concentration 0.5 mg/mL
Conjugation FITC
Preservative and Stabilizer < 0.1% Sodium Azide
Buffer Phosphate Buffered Saline
Physical State Liquid

Target Information

Porcine CD21, also known as complement receptor 2 (CR2), is a protein expressed on the surface of B cells and some T cells in pigs. It plays a significant role in the immune system by facilitating the interaction of B cells with antigens and the activation of the complement system. pCD21 is involved in the binding of complement component C3d to B cells, which enhances the ability of B cells to recognize and respond to antigens. This process is crucial for the activation, proliferation, and differentiation of B cells into antibody-producing plasma cells.

Target Porcine CD21

Shipping and Storage

This product is shipped with ice gel packs. Store at 2°C - 8°C (up to 12 months) on receipt. Avoid exposure to light.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Goldeck, David, et al. "Establishment of systems to enable isolation of porcine monoclonal antibodies broadly neutralizing the porcine reproductive and respiratory syndrome virus." Frontiers in Immunology 10 (2019): 572.
Inquiry Basket